Fig. 2.

Mean change from baseline (±SE) at each visit in the pooled Phase III studies: a the number of incontinence episodes/24 h (full analysis set-incontinence), b number of number of micturitions/24 h (full analysis set), and c volume voided/micturition (full analysis set). ^#Statistically significant treatment benefit relative to placebo (P < 0.05) with multiplicity adjustment. *Statistically significant treatment benefit relative to placebo (P < 0.05) without multiplicity adjustment. SE standard error, FAS full analysis set